FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/12/2026
Back to search
Official data from USPTO
PP PAION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
08/12/2026
Trademark type
Combined
Nice classes
1, 5, 35
Filing date
04/02/2025
Registration date
05/12/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2026
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
DE
Examiner
FOX III, LYAL L
Law office
M40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized lettering "PP" where the first "P" is backwards and there is a shaded square between the letters which are on the left side of the stylized wording "PAION".
Holders and representatives
Holders
Paion Pharma GmbH
Representatives
Leigh Ann Lindquist Sughrue Mion, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalsbiological preparationsbiochemical preparations for use in industry and science; Chemicals for use in biotechnological manufacturing processes
Class 5
Chemical and biochemical preparations for pharmaceutical or medical purposes for the prevention and treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunctionpain; Biological reagents for medical purposes; Biologics in the nature of pharmaceutical preparations for the treatment of for the prevention and treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunctionpain; Biochemical reagents for medical purposes; Diagnostic preparations for medical purposes; Reagents for medical purposes; Vaccines; Pharmaceutical preparations for the prevention and treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunctionpain; Sedatives; Anaesthetics; Hypnotics; Anxiolytics; Muscle relaxants; Anticonvulsants; Analgesics; Antibiotic preparations; Antiparasitics; Antihypertensives; Antihypotensives; Pharmaceutical preparationsimmunostimulants; Pharmaceutical preparations for gene therapy for the treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunctionpain
Class 35
Wholesale store servicesretail store servicesmail order servicesonline wholesale store servicesonline retail store services featuring chemicalbiologicalbiochemical preparations for industrialscientificmedicalveterinary and pharmaceutical purposesalso featuring diagnostic preparations for medical purposesreagents for medical purposesvaccinespharmaceutical preparationspharmaceuticals
Publications
History of USPTO decisions and trademark events.
26 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/12/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/24/2026
PUBO
PUBLISHED FOR OPPOSITION
03/24/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/18/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/27/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/27/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/27/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/27/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/21/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/21/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/21/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/21/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/21/2026
RFNT
REFUSAL PROCESSED BY IB
11/07/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/17/2025
RFRR
REFUSAL PROCESSED BY MPU
10/17/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/03/2025
CNRT
NON-FINAL ACTION WRITTEN
09/02/2025
DOCK
ASSIGNED TO EXAMINER
08/29/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/23/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/23/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/22/2025
Continuous trademark protection
Get notified about every new filing that threatens PP PAION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.